Goterra, the Canberra startup that raised $36.5 million to turn food waste into protein using black soldier fly larvae, has entered liquidation. Administrators received no viable offers to save the business.
Teneo's Daniel Walley and Martin Ford are handling the wind-up. Their creditor report cites "ongoing losses that arose as the Company attempted to develop its waste technology and build the business to scale."
The numbers tell the story: revenue grew from $365,000 in FY23 to $1.43M in the 11 months to May 2026. The company also claimed $5.97M in R&D tax offsets in FY25 and another $4.49M the following year. But revenue growth could not cover the cost of building autonomous insect farms at scale.
Founded in 2014 by CEO Olympia Yarger, Goterra spent approximately $25 million developing IP, regulatory approvals, and modular systems. The Series A was led by Grok Ventures and Tenacious Ventures. Not enough.
What this means for the team: administrators noted the company is "continuing to trade at a reduced level," which typically means skeleton crew or full stop. No public detail on headcount before administration or how many sales or operations roles existed. For anyone who joined in the growth phase, this is the startup failure playbook: equity goes to zero, unvested options disappear, and you are back on the market.
Broader context: Goterra's collapse highlights the funding gap for capital-intensive agtech. Early traction (customers, revenue growth, R&D credits) is not enough when you need $50M+ to reach unit economics that work. The administrator warned of "contagion" concerns across the insect ag sector, where multiple startups face similar scaling challenges.
For sales professionals evaluating early-stage roles: revenue growth is necessary but not sufficient. Ask about burn rate, runway, and the capital required to reach profitability. If the answer is "we will raise more," get specific about timing and backup plans.